SG11202113005SA - Method of reconstituting liposomal annamycin - Google Patents
Method of reconstituting liposomal annamycinInfo
- Publication number
- SG11202113005SA SG11202113005SA SG11202113005SA SG11202113005SA SG11202113005SA SG 11202113005S A SG11202113005S A SG 11202113005SA SG 11202113005S A SG11202113005S A SG 11202113005SA SG 11202113005S A SG11202113005S A SG 11202113005SA SG 11202113005S A SG11202113005S A SG 11202113005SA
- Authority
- SG
- Singapore
- Prior art keywords
- reconstituting
- liposomal annamycin
- annamycin
- liposomal
- reconstituting liposomal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962868190P | 2019-06-28 | 2019-06-28 | |
| PCT/US2020/039621 WO2020264161A1 (en) | 2019-06-28 | 2020-06-25 | Method of reconstituting liposomal annamycin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202113005SA true SG11202113005SA (en) | 2021-12-30 |
Family
ID=74061076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202113005SA SG11202113005SA (en) | 2019-06-28 | 2020-06-25 | Method of reconstituting liposomal annamycin |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220105116A1 (en) |
| EP (1) | EP3990041A4 (en) |
| JP (1) | JP2023523872A (en) |
| KR (1) | KR20220027941A (en) |
| CN (2) | CN114728101B (en) |
| AU (1) | AU2020302784A1 (en) |
| BR (1) | BR112021026480A2 (en) |
| CA (1) | CA3144443A1 (en) |
| IL (1) | IL289433A (en) |
| MX (1) | MX2021015667A (en) |
| SG (1) | SG11202113005SA (en) |
| TW (1) | TW202114704A (en) |
| WO (1) | WO2020264161A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021026506A2 (en) | 2019-06-28 | 2022-02-15 | Univ Texas | Method for making lyophilized anamycin, method for producing pre-liposomal anamycin lyophilizate, pre-liposomal anamycin lyophilizate composition, and method for treating cancer |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IS1685B (en) * | 1990-12-11 | 1998-02-24 | Bracco International B.V. | Method of making liposomes that are endowed with enhanced ability to absorb and contain foreign matter |
| US5902604A (en) * | 1995-06-06 | 1999-05-11 | Board Of Regents, The University Of Texas System | Submicron liposome suspensions obtained from preliposome lyophilizates |
| WO2001032145A1 (en) * | 1999-10-29 | 2001-05-10 | Board Of Regents, The University Of Texas System | Method of cancer treatment |
| CA2515892C (en) * | 2003-02-14 | 2012-10-23 | Children's Hospital & Research Center At Oakland | Lipophilic drug delivery vehicle and methods of use thereof |
| JP5890785B2 (en) * | 2010-03-10 | 2016-03-22 | センプラ ファーマシューティカルズ，インコーポレイテッド | Parenteral preparations of macrolide antibiotics |
| HUE044352T2 (en) * | 2011-10-14 | 2019-10-28 | Hoffmann La Roche | Pertuzumab, trastuzumab, docetaxel and carboplatin for the treatment of early-stage breast cancer |
| JP6133308B2 (en) * | 2011-10-21 | 2017-05-24 | セレーター ファーマシューティカルズ インコーポレイテッド | Lyophilized liposome |
| CN107569508A (en) * | 2016-07-05 | 2018-01-12 | 江苏竞诺择生物医药科技有限公司 | A kind of Pharmaceutical composition for treating hemopoietic system proliferative diseases |
| WO2019023873A1 (en) * | 2017-07-31 | 2019-02-07 | 江苏竞诺择生物医药科技有限公司 | Nano-lipid microparticle composition and pharmaceutical composition for treating hematopoietic system proliferative diseases |
-
2020
- 2020-06-25 EP EP20832031.7A patent/EP3990041A4/en active Pending
- 2020-06-25 CN CN202080048890.7A patent/CN114728101B/en active Active
- 2020-06-25 SG SG11202113005SA patent/SG11202113005SA/en unknown
- 2020-06-25 BR BR112021026480A patent/BR112021026480A2/en unknown
- 2020-06-25 AU AU2020302784A patent/AU2020302784A1/en active Pending
- 2020-06-25 KR KR1020227000486A patent/KR20220027941A/en unknown
- 2020-06-25 WO PCT/US2020/039621 patent/WO2020264161A1/en active Application Filing
- 2020-06-25 JP JP2021577862A patent/JP2023523872A/en active Pending
- 2020-06-25 CA CA3144443A patent/CA3144443A1/en active Pending
- 2020-06-25 MX MX2021015667A patent/MX2021015667A/en unknown
- 2020-06-25 CN CN202310738252.3A patent/CN116785242A/en active Pending
- 2020-06-29 TW TW109121840A patent/TW202114704A/en unknown
-
2021
- 2021-12-17 US US17/554,553 patent/US20220105116A1/en active Pending
- 2021-12-27 IL IL289433A patent/IL289433A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN114728101B (en) | 2023-07-14 |
| CN116785242A (en) | 2023-09-22 |
| CN114728101A (en) | 2022-07-08 |
| IL289433A (en) | 2022-02-01 |
| AU2020302784A1 (en) | 2022-01-20 |
| EP3990041A4 (en) | 2023-07-12 |
| EP3990041A1 (en) | 2022-05-04 |
| WO2020264161A1 (en) | 2020-12-30 |
| US20220105116A1 (en) | 2022-04-07 |
| MX2021015667A (en) | 2022-04-18 |
| CA3144443A1 (en) | 2020-12-30 |
| BR112021026480A2 (en) | 2022-02-08 |
| TW202114704A (en) | 2021-04-16 |
| JP2023523872A (en) | 2023-06-08 |
| KR20220027941A (en) | 2022-03-08 |
| US20240024345A1 (en) | 2024-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3287444A4 (en) | New crystal form of lenvatinib methanesulfonate salt and preparation method thereof | |
| EP3411758A4 (en) | Participation factor based method for resynchronization of microgrids | |
| EP3751001A4 (en) | Ergothioneine production method | |
| EP3516713A4 (en) | Method of preparing electrode assemblies | |
| EP3804853A4 (en) | Preparation method for s-indoxacarb | |
| IL280703A (en) | Method for preparing liposomes | |
| EP4081687A4 (en) | Method of construction | |
| EP3677575A4 (en) | Crystalline form of ozanimod hydrochloride and preparation method therefor | |
| EP3447967A4 (en) | Method and apparatus for convergence of multiple networks | |
| EP3696168A4 (en) | Method for preparation of 2-chloro-5-trifluoromethylpyridine | |
| IL289433A (en) | Method of reconstituting liposomal annamycin | |
| EP3770239A4 (en) | Preparation method of microcapsules | |
| EP3321273A4 (en) | Preparation method of diosmin | |
| IL282108A (en) | Preparation method for efinaconazole | |
| EP3269703A4 (en) | Method of isomerizing diaminodicyclohexylmethane | |
| ZA202005380B (en) | Method for isolation of cytisine | |
| EP3989910A4 (en) | Method for the production of pullulan soft capsules | |
| EP3962460A4 (en) | Method for the production of pullulan capsules | |
| HUE056705T2 (en) | Method for the preparation of di- and polyamines of the diphenyl methane series | |
| GB201906840D0 (en) | Method of deposition | |
| EP3890780A4 (en) | Method of treatment | |
| GB2582177B (en) | Method of processing layered structures | |
| GB2602912B (en) | Method of packaging | |
| EP3947282A4 (en) | Method of preparing cyclosilane | |
| AU2019904948A0 (en) | Method of construction |